Stem Cells for Cardiovascular Disease 2009Select Biosciences LimitedJanuary 1, 2009 106 Pages - SKU: SBS2068677 |
| This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences, based on our continual industry coverage. Select Biosciences industry coverage in this report focuses on the technical, market, and clinical trials aspects of stem cells being developed for addressing the opportunities in the cardio and vascular disease spaces. Major emphasis is placed on the various clinical applications of mesenchymal stem cells (MSCs)—a key stem cell lineage of paramount importance for regenerative medicine. A Major Focus of this Report is on the Market Landscape and Quantitative Market Trends in Cardiovascular Disease utilizing various types of stem cell classes/lineages. Another key focus of this report is on the various clinical trials either completed or in progress addressing different therapeutic areas across the cardiovascular diseases landscape. Extensive Worldwide Market Analyses Presented in this Report: Results and Analyses from Stem Cells-Focused Market Surveys Administered to Large Respondent Pools of Industry Participants focused on Stem Cells—Qualitative and Quantitative Market Trends are Analyzed and Presented focusing on the cardiovascular disease spaces Breakout of the Market by Types of Stem Cells Utilized and Application Areas—in various therapeutic segments of the cardiovascular disease therapeutics marketplace Quantitative Breakout of various types of stem cells in research and clinical development for cardiovascular diseases Breakout of the Market by Therapeutic/Disease Segments Addressed—in the various segments of the cardiovascular disease space Worldwide Stem Cells-focused Clinical Trials for Cardiovascular Diseases Qualitative and Quantitative Trends Sponsoring Institutions/Companies Types of Trials Types of Cells Utilized Clinical End-Points Progress Reports Competitive Landscape: Companies Focused on Developing Stem Cells-focused Cellular Therapies for Different Disease Areas in the Cardiovascular Space—Qualitative and Quantitative Analyses Impact of Mesenchymal Stem Cells (MSCs) and other stem/progenitor cell types for mediating cardiovascular disease regenerative medicine Mechanisms of action of MSCs in cardiovascular disease regenerative medicine Delivery approaches for cellular therapy of cardiovascular diseases Companies Profiled in This Market Report: Aastrom Biosciences Aldagen Angioblast Systems Arteriocyte Athersys Bioheart Cytori Geron Medistem Mytogen Osiris Therapeutics Pluristem t2cure TheraVitae |
Related Markets
Cardiovascular Reports
- Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success
- Biomarkers: Applications and Trends
- Biomarkers- Advanced Technologies and Global Market (2009-2014)
- U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market
- hERG: Technology and Market Analysis
